Quorum Health Corporation (QHC) Upgraded at Zacks Investment Research

Remigio Civitarese
Agosto 12, 2017

On April 1, 2016, Community Health Systems, Inc. announced that its board of directors has approved the distribution to its stockholders of 100% of the common stock of a new, independent publicly traded company, Quorum Health Corporation. The analysts, on average, are forecasting a $2.56 price target, but the stock is already up 12.5% from its recent lows. The average 12 month target price among brokerages that have updated their coverage on the stock in the past year is $4.35.

Several analysts have recently commented on QHC shares.

Analysts' mean recommendation for Quorum Health Corporation (QHC) stands at 3.30. Morgan Stanley assumed coverage on shares of Quorum Health Corporation in a report on Tuesday, June 6th. They issued an "underweight" rating and a $3.00 price target for the company. Zacks Investment Research upgraded shares of Quorum Health Corporation from a "hold" rating to a "buy" rating and set a $4.50 price target for the company in a research report on Saturday, July 22nd.

Shares of Quorum Health Corporation (NYSE:QHC) traded down 1.87% during mid-day trading on Monday, hitting $3.14. These holdings make up 91.68% of the company's outstanding shares. The company has market cap of $108.18 million. The firm has a 50-day moving average price of $3.87 and a 200 day moving average price of $5.58.

Quorum Health Corp (NYSE:QHC) has declined 66.10% since August 10, 2016 and is downtrending.

In terms of earnings per share, 6 analysts have a -0.36 EPS mean target for the quarter ending Sep-17, for the quarter ending Dec-17, 6 analysts have a 0.24 EPS mean target and for the quarter ending Dec-17 there are 5 estimates of -1.57 EPS. The business had revenue of $527.60 million for the quarter, compared to the consensus estimate of $548.81 million. Quorum Health Corporation had a negative net margin of 7.13% and a negative return on equity of 57.09%. The company's revenue for the quarter was up.1% on a year-over-year basis.

They expect $-0.64 EPS, up 59.38% or $0.38 from last year's $-1.02 per share.

ILLEGAL ACTIVITY NOTICE: This piece of content was first posted by Markets Daily and is the property of of Markets Daily. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of global trademark & copyright legislation. The original version of this report can be accessed at https://weekherald.com/2017/08/12/quorum-health-corporation-qhc-lifted-to-buy-at-zacks-investment-research-updated-updated.html. Also, insider Thomas Daniel Miller acquired 185,000 shares of the business's stock in a transaction dated Thursday, May 18th. The shares were bought at an average price of $2.85 per share, for a total transaction of $527,250.00. Following the acquisition, the insider now owns 814,139 shares in the company, valued at approximately $2,320,296.15. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Shaheed Koury bought 8,500 shares of the firm's stock in a transaction that occurred on Thursday, May 25th. The stock was bought at an average price of $3.56 per share, with a total value of $30,260.00. Following the transaction, the senior vice president now directly owns 88,680 shares of the company's stock, valued at approximately $315,700.80. The disclosure for this purchase can be found here. Company insiders own 4.70% of the company's stock.

A number of hedge funds have recently made changes to their positions in QHC. Kohlberg Kravis Roberts & Co. Comerica Bank raised its stake in Quorum Health Corporation by 5.1% in the fourth quarter. 78,296 shares of the stock were exchanged. Lastly, Teachers Advisors raised its stake in stocks of Quorum Health Corporation by 51.9% in the Q4. Institutional investors own 87.88% of the company's stock. Goldman Sachs Group Inc. boosted its stake in shares of Quorum Health Corporation by 111.3% in the first quarter. In the last 90 days, insiders have purchased 197,500 shares of company stock valued at $568,190. NY raised its stake in Quorum Health Corporation by 853.3% in the fourth quarter. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Quorum Health Corporation by 20.7% in the second quarter. FMR LLC now owns 440,547 shares of the company's stock valued at $1,828,000 after buying an additional 81,485 shares during the last quarter.

The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR). The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR).

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE